Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-005845
Filing Date
2025-04-29
Accepted
2025-04-29 16:15:12
Documents
24
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A ewtx-20250613xdef14a.htm DEF 14A 1099952
2 GRAPHIC ewtx-20250613xdef14a_a003.jpg GRAPHIC 1679
3 GRAPHIC ewtx-20250613xdef14a_a004.jpg GRAPHIC 2027
4 GRAPHIC ewtx-20250613xdef14a_a005.jpg GRAPHIC 1636
5 GRAPHIC ewtx-20250613xdef14a_a006.jpg GRAPHIC 1826
6 GRAPHIC ewtx-20250613xdef14a_a007.jpg GRAPHIC 1649
7 GRAPHIC ewtx-20250613xdef14a_a008.jpg GRAPHIC 1537
8 GRAPHIC ewtx-20250613xdef14a_a009.jpg GRAPHIC 1654
9 GRAPHIC ewtx-20250613xdef14a_a010.jpg GRAPHIC 1566
10 GRAPHIC ewtx-20250613xdef14a_a011.jpg GRAPHIC 2107
11 GRAPHIC ewtx-20250613xdef14a_a012.jpg GRAPHIC 4508
12 GRAPHIC ewtx-20250613xdef14a_a013.jpg GRAPHIC 2251
13 GRAPHIC ewtx-20250613xdef14a_a014.jpg GRAPHIC 3997
14 GRAPHIC ewtx-20250613xdef14a_a015.jpg GRAPHIC 1967
15 GRAPHIC ewtx-20250613xdef14a_a016.jpg GRAPHIC 2793
16 GRAPHIC ewtx-20250613xdef14a_a017.jpg GRAPHIC 2128
17 GRAPHIC ewtx-20250613xdef14a_a021.jpg GRAPHIC 2367
18 GRAPHIC ewtx-20250613xdef14a_a022.jpg GRAPHIC 2061
19 GRAPHIC ewtx-20250613xdef14a_a023.jpg GRAPHIC 1668
20 GRAPHIC ewtx-20250613xdef14a_a030.jpg GRAPHIC 33156
21 GRAPHIC ewtx-20250613xdef14a_a031.jpg GRAPHIC 29596
22 GRAPHIC ewtx-20250613xdef14a_a036.jpg GRAPHIC 2200
23 GRAPHIC ewtx-20250613xdef14a_bg001.jpg GRAPHIC 133360
24 GRAPHIC ewtx-20250613xdef14a_bg002.jpg GRAPHIC 88715
  Complete submission text file 0001558370-25-005845.txt   1546387
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40236 | Film No.: 25887779
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)